A neuromodulatory role of interleukin-1β in the hippocampus
暂无分享,去创建一个
Detlef Balschun | D. Balschun | F. Pitossi | H. Besedovsky | Hugo O. Besedovsky | H Schneider | F Pitossi | A Wagner | A del Rey | A. Rey | H. Schneider | A. Wagner
[1] J. Sarvey,et al. Blockade of norepinephrine-induced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis , 1985, Brain Research.
[2] D. Baly,et al. Interleukin‐1 stimulates glucose transport in rat adipose cells , 1990 .
[3] C. Pert,et al. Visualization and characterization of interleukin 1 receptors in brain. , 1987, Journal of immunology.
[4] B. Hogan,et al. Manipulating the mouse embryo: A laboratory manual , 1986 .
[5] K. Schauenstein,et al. NEUROIMMUNOMODULATION VIA LIMBIC STRUCTURES — THE NEUROANATOMY OF PSYCHOIMMUNOLOGY , 1997, Progress in Neurobiology.
[6] M. Labow,et al. Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[7] M. Krug,et al. Anisomycin blocks the late phase of long-term potentiation in the dentate gyrus of freely moving rats , 1984, Brain Research Bulletin.
[8] E. Kandel,et al. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Kanba,et al. Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[10] A. Arimura,et al. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. , 1987, Endocrinology.
[11] Y. Kiso,et al. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. , 1990, European journal of pharmacology.
[12] H. Besedovsky,et al. Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.
[13] J. Licinio,et al. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. McIntyre,et al. Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist , 1995, The Journal of Biological Chemistry.
[15] H. Besedovsky,et al. Antidiabetic effects of interleukin 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[16] N. Rothwell,et al. Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.
[17] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[18] T. Dj,et al. Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. , 1992 .
[19] T. Bliss,et al. A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.
[20] C. Dinarello,et al. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain. , 1991, Molecular pharmacology.
[21] A. Arimura,et al. Identification of a high-affinity receptor for interleukin-1 beta in rat brain. , 1988, Biochemical and biophysical research communications.
[22] C. Newton,et al. Spatial Learning Impairment in Mice Infected with Legionella pneumophila or Administered Exogenous Interleukin-1-β , 1995, Brain, Behavior, and Immunity.
[23] U. Frey,et al. Synaptic tagging and long-term potentiation , 1997, Nature.
[24] P. Sawchenko,et al. Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.
[25] A. Dunn,et al. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. , 1988, Life sciences.
[26] J. Sarvey,et al. Blockade of long-term potentiation in rat hippocampal CA1 region by inhibitors of protein synthesis , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] M. Manthorpe,et al. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor‐dependent mechanism , 1997, Journal of neuroscience research.
[28] H. Besedovsky,et al. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. , 1987, Science.
[29] G. Siggins,et al. Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus , 1993, Brain Research.
[30] M R Rosenzweig,et al. Aspects of the search for neural mechanisms of memory. , 1996, Annual review of psychology.
[31] J. J. O'Connor,et al. Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro , 1996, Neuroscience Letters.
[32] R. Dantzer,et al. Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.
[33] C Chen,et al. Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. , 1997, Annual review of neuroscience.
[34] E. Kandel,et al. Mice Expressing Activated CaMKII Lack Low Frequency LTP and Do Not Form Stable Place Cells in the CA1 Region of the Hippocampus , 1996, Cell.
[35] H. Besedovsky,et al. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain , 1988, Brain, Behavior, and Immunity.
[36] Robert C. Malenka,et al. Synaptic plasticity in the hippocampus: LTP and LTD , 1994, Cell.
[37] C. Dinarello,et al. Characterization of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. , 1989, Cytokine.
[38] R. Sapolsky,et al. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. , 1987, Science.
[39] M. Oitzl,et al. Interleukin-1β, but not interleukin-6, impairs spatial navigation learning , 1993, Brain Research.
[40] K. Reymann,et al. A post-tetanic time window for the reinforcement of long-term potentiation by appetitive and aversive stimuli. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] David J. Anderson,et al. Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain , 1996, Cell.
[42] P. Braquet,et al. Platelet-activating factor and cellular immune responses. , 1987, Immunology today.
[43] L. Rawlinson,et al. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. , 1992, The Journal of biological chemistry.